Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels Authors: Maria do Carmo Costa, Fernanda Bajanca, Ana-João Rodrigues, Ricardo J. Tomé, Garry Corthals, Sandra Macedo-Ribeiro, Henry L. Paulson, Elsa Logarinho, Patrícia Maciel Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0011728 ABSTRACT During myogenesis several transcription factors and regulators of protein synthesis and assembly are rapidly degraded by the ubiquitin-proteasome system (UPS). Given the potential role of the deubiquitinating enzyme (DUB) ataxin-3 in the UPS, and the high expression of the murine ataxin-3 homolog in muscle during embryogenesis, we sought to define its role in muscle differentiation. Using immunofluorescence analysis, we found murine ataxin-3 (mATX3) to be highly expressed in the differentiated myotome of E9.5 mouse embryos. C2C12 myoblasts depleted of mATX3 by RNA interference exhibited a round morphology, cell misalignment, and a delay in differentiation following myogenesis induction. Interestingly, these cells showed a down-regulation of α5 and α7 integrin subunit levels both by immunoblotting and immunofluorescence. Mouse ATX3 was found to interact with α5 integrin subunit and to stabilize this protein by repressing its degradation through the UPS. Proteomic analysis of mATX3-depleted C2C12 cells revealed alteration of the levels of several proteins related to integrin signaling. Ataxin-3 is important for myogenesis through regulation of integrin subunit levels. INTRODUCTION Myogenesis is the process of differentiation of muscle precursor cells (MPCs) into multinucleated myotubes that mature into myogenic fibers [1] , [2] . This is strictly regulated by two families of transcription factors: the myogenic regulatory factors (MRFs), and the myocyte enhancer-binding factor 2 (MEF2). The MRFs, consisting of Myf5, MyoD, MRF4 and myogenin, usually forming heterodimers with ubiquitous E-proteins (E12 or E47) [3] , act in combination with MEF2 transcription factor family to activate many muscle-specific genes [4] . For successful myogenesis many cellular processes must occur, directed by transcriptional regulation by MRFs and MEF2, intracellular signaling, cell migration, cell-cell interaction, and cell connections with the extracellular matrix (ECM). Integrins are important players in these processes. These transmembrane cell surface ECM receptors form heterodimers composed of an α and β subunits [5] . Clustering of integrins upon matrix binding provides a bidirectional crosstalk between the inside and outside signaling. As a consequence of cell-matrix adhesions, several proteins are recruited to the adhesion complexes, activating signaling cascades that control cytoskeletal organization, gene regulation, and diverse cellular processes and functions [6] . In vitro and in vivo studies in avian and rodent species showed that α4β1, αVβ1, α5β1, α6β1, and α7β1 integrins are the major players in skeletal muscle development [7] . It is crucial that the synthesis, degradation, and assembly of many proteins be closely regulated at each phase of muscle development. Many transcription factors and other proteins participating in the aforementioned processes are rapidly degraded by the UPS, including MyoD [8] , Myf5 [9] , myogenin [10] , Pax3 [11] , Id proteins [12] , β-catenin [13] , [14] , and α5 integrin subunit [15] . The reversal of ubiquitination, catalyzed by deubiquitinating (DUB) enzymes, is equally important in several cellular processes. So far, only two DUBs, UBP45 and UBP69, have been implicated in myogenesis but their specific role is still unknown [16] . Thus, it remains to be determined how the removal of ubiquitin from certain proteins by DUBs contributes to muscle development. Ataxin-3 (ATX3) is the best characterized member among a small new subclass of DUBs [17] . DUB activity in ATX3 is conferred by the N-terminal josephin domain, carrying the essential Cysteine 14 (C14) residue responsible for its protease activity [18] , [19] , [20] . Several lines of evidence suggest that ATX3 may function in the UPS: (1) it binds and hydrolyses polyubiquitin chains in vitro [21] , [22] , [23] , [24] ; (2) it interacts with ubiquitin (Ub) and NEDD8, a ubiquitin-like (UBL) protein that regulates the activity of E3 ligases [25] ; and (3) it associates with the proteasome through interactions with p45 (an ATPase subunit of the 19S proteasome subunit) [26] , VCP/p97 (an AAA ATPase important for the shuttling of many polyubiquitinated proteins to the proteasome) [27] , [28] , and Ubxn-5 [29] . ATX3, an ubiquitously expressed protein that contains a polyglutamine (polyQ) tract near its C-terminus that is neighbored by two or three ubiquitin interacting motifs (UIMs) [24] , depending on the protein isoform. In humans, this polyQ segment usually consists of 12–44 glutamines, but it is expanded to ∼60–87 glutamines in Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3). MJD is the most common dominantly inherited cerebellar ataxia in the world [30] . The neurological phenotype in MJD, which can range widely, has been classified into at least three subtypes with characteristic features: cerebellar ataxia with ophthalmoparesis and pyramidal tract signs (type II), with additional extrapyramidal signs (type I), or with distal muscular atrophy (type III) [31] . In early descriptions of MJD, muscle alterations were observed although studies of muscle involvement have been limited [31] , [32] , [33] . ATX3 is a highly conserved protein throughout evolution. We previously observed that the murine homolog (mATX3) exhibits ubiquitous expression, including during embryonic development [34] . Furthermore, mATX3 is highly expressed in muscle cells from embryonic development through adult ages, and its transcription is activated to a great extent in muscle-differentiated P19 cells [34] . To date, besides a potential involvement of ATX3 in transcriptional repression, DNA repair [35] , and in endoplasmic reticulum associated protein degradation (ERAD) [28] , no other cellular functions for ATX3 are known, and no physiological substrates for its DUB activity have been identified. In this study we assessed the role of mATX3 in muscle differentiation. We found that mATX3 is strongly expressed in the early myotome of E9.5 mouse embryos, and it colocalizes with myosin in differentiated myogenic fibers. We found that mATX3 depletion in C2C12 cells perturbs the phenotypical response to differentiation induction, such as cell alignment and elongation, and also cellular proliferation. In addition, we observed that levels of α5 and α7 integrin subunits, as well as many other proteins implicated in the integrin signaling pathway, were altered in mATX3-depleted cells. Altogether, our data suggest that mATX3 is contributing to muscle differentiation by preventing the degradation of integrin subunits through the UPS. RESULTS To characterize the expression of mATX3 in the developing muscle, we performed double immunofluorescence labeling for mATX3 and myogenic markers in mouse embryo sections from E9.5 to E18.5. Although being broadly expressed, detected in the dermomyotome, and throughout the whole extent of the myotome, mATX3 is surprisingly up-regulated at E9.5 in elongated myogenin-positive cells ( Figure 1A ). This expression pattern is also observed at in the differentiated myotome at E11.5 ( Figure 1B ). Maximum projection of confocal optical z-series from sagittal 15 µm sections of E9.5 (A), E11.5 (B), E14.5 (C) and E18.5 (D) mouse embryos labeled for mATX3 and the myogenic differentiation markers myogenin (A, B) or myosin (C, D). (A) mATX3 (green, arrows) is highly upregulated in differentiated myogenin-positive cells (red) when comparing with younger myogenin-negative cells in the myotome (arrowheads). (B) strong staining for mATX3 (green, arrows) remains present in E11.5 elongated myogenin-positive myocytes (red). (C) E14.5 intercostal muscle showing a fiber-like labeling pattern of mATX3 (green) colocalising with myosin-positive fibers (red). (D) mATX3 (green, arrows) remains strongly expressed at late fetal stages in myosin-positive fibers (red). (E) mATX3 (green) is expressed in adult myosin fibers (red). (1) mATX3 staining, (2) myosin (MHC) or myogenin labeling, (3) triple overlay of mATX3, myogenic marker, and DAPI. Scale bars represent 80 µm. Immunoreactivity was also detected in muscle fibers analyzed later on (E14.5, E18.5, and adult) with no predominance in muscle type ( Figure 1C, D, E ). The expression pattern suggests that mATX3 is present in all stages of myogenesis, with highest immunoreactivity in earlier stages of differentiation. Therefore, ATX3 may be implicated in muscle development. ATAXIN-3 DEPLETION PERTURBS THE PHENOTYPE OF DIFFERENTIATING C2C12 CELLS To study the role of mATX3 in myogenic differentiation we transfected C2C12 myoblast cells with siRNA targeting the Mjd transcript, and induced their differentiation by switching from growth medium (GM) to a serum-limited differentiation medium (DM). The expression levels of mATX3 in Mjd siRNA-depleted cell extracts collected over time were analyzed by immunoblotting and compared with controls (mock transfection). The choice of the ideal time point to induce differentiation (Day 0) was based on the maximum suppression of mATX3 expression obtained two days after Mjd siRNA transfection (Day -2), with a reduction to about 18% of normal mATX3 levels ( Figure 2A, B ). In a pattern consistent with a putative role in myogenic differentiation, mATX3 levels in C2C12 control cells increase upon induction of differentiation at Day 0 ( Figure 2A, B , mock). Cells were transfected at Day -2 and maintained in growth medium (GM) for 48 hrs (Day 0), then the medium was replaced by differentiation medium (DM) and changed every day until Day 5. (A) Whole cell extracts of undifferentiated (Day -2 and Day 0) and differentiated cells (Day 1 to Day 5) were analyzed for mATX3, MyoD and α-tubulin in mock and Mjd siRNA transfected cells. The amounts of ataxin-3 and MyoD were determined by immunoblotting. The myogenic factor MyoD is not a target of mATX3. Both mock and Mjd siRNA-transfected cells show that this MRF is upregulated upon differentiation. (B) Relative band density of mATX3 in each day (comparing with Day -2) shows that the Mjd siRNA has maximum efficiency two days after transfection (Day 0). The results were normalized for α-tubulin and correspond to the average of three independent transfections ± SEM (error bars). * statistical significance p<0.05 using Student t-test. (C) Phenotype of the Mjd siRNA C2C12 cells during differentiation. At Day 0 and Day 1, when mATX3 depletion is higher, the Mjd siRNA cells show extensive cell-cell misalignment, and rounder shape compared to mock-transfected cells. Although the mATX3 levels were partially restored at Day 5, the knocked-down cells still present some misalignment. (D) The maximum projection of confocal optical z-series images of mATX3 and myosin double-stained cells at differentiation Day 5. In contrast to mock control cells that show a well organized myosin cytoskeleton (arrows), mATX3-depleted cells show an abnormally fragmented myosin staining with a very short filament pattern. (1) mATX3 staining, (2) myosin (MHC) labeling, (3) triple overlay of mATX3, myogenic marker, and DAPI (DNA marker). Scale bars represent 10 µm. After induction of differentiation (Day 0 to Day 5), Mjd siRNA-transfected cells were phenotypically different from mock-transfected cells: cell shape was rounder, with very thin cell extensions and extensive cell-cell misalignment ( Figure 2C ). At Day 5 the mATX3-depleted cells showed a very immature cytoskeleton, with myosin-containing filaments fragmented in the cytoplasm that failed to elongate as their control counterparts ( Figure 2D ). To exclude the possibility that the use of a dicer-generated pool of Mjd siRNAs might be interfering with other similar mRNAs, we analyzed the levels of the transcripts encoding the josephin-domain proteins ( Josd1 and Josd2 ). Quantitative real-time PCR revealed no significant differences for these transcripts between mock and Mjd siRNA transfected C2C12 cells at Days 0 and 1 of differentiation ( Figure S1 ). These results suggest that the phenotype observed in C2C12 cells transfected with Mjd siRNA was specifically due to mATX3 knockdown, and that this protein is required during the differentiation process. Consistently, at Day 5, when mATX3 levels were restored to the levels of Day -2, the phenotype started to revert ( Figure 2C ). To determine whether the mATX3-depletion phenotype was due to direct alteration of the myogenic transcriptional program, we analyzed the levels of the myogenic regulatory factors MyoD ( Figure 2A ) and myogenin (not shown) by immunoblotting. No differences were observed between Mjd siRNA and mock-transfected differentiated cells, suggesting that mATX3 does not perturb the onset of the myogenic program but has instead downstream targets. ATAXIN-3 REGULATES Α5 AND Α7 INTEGRIN SUBUNIT LEVELS DURING MYOGENIC DIFFERENTIATION Providing a link between the extracellular matrix and the cell cytoskeleton, integrins play a critical role for the cytoskeletal modifications induced by myogenic differentiation. We sought to determine whether the abnormal phenotype of mATX3-depleted cells could be due to a perturbation on integrin levels and analyzed the expression pattern of two integrin subunits known to play a role in myogenesis: α5 integrin subunit and α7 integrin subunit. Immunoblotting detection of α5, α7(A+B) and α7B integrin subunits in mock transfected C2C12 cells revealed that while the α5 subunit shows an immediate increase upon differentiation, and the α7 subunits increase more progressively ( Figure 3A, B ), which is in accordance with previously described expression patterns [36] . In contrast, we observed a decrease in the expression of both integrin subunits in Mjd siRNA-treated cells ( Figure 3A, B ). Interestingly, the α7 subunits levels were consistently maintained low until Day 5, while the α5 subunit levels decreased significantly from Day 0 to Day 2, and then started to increase at Day 3 until Day 5. This suggests that the α5 integrin subunit may be directly dependent on the levels of mATX3, registering a recovery as Mjd siRNA loses effect (see Figure 2 A, B ). In contrast, the α7 integrin subunit levels were not able to recover during the experiment time course, suggesting that the relation with mATX3 may be indirect or that the effect of mATX3 depletion is less reversible in this case. The results obtained by immunoblotting were confirmed by co-immunostaining of mATX3 and α5 integrin subunit at Days 0 and 3 and mATX3 and α7 integrin subunit at Day 3 in Mjd siRNA-transfected C2C12 cells ( Figure 4 ). Despite some increase of mATX3 levels at Day 3, comparing to Day 0 and Day 1, the Mjd siRNA cells still exhibited round shape, cell-cell misalignment and decreased amounts of α5 and α7 integrin subunits ( Figure 4 ). (A) The amounts of α5 and α7 integrin subunits were determined by immunoblotting. Whole cell extracts of undifferentiated (Day -2 and Day 0) and differentiated cells (Day 1 to Day 5) were analyzed for α5 and α7 integrin subunits and α-tubulin in mock and Mjd siRNA transfected cells. (B) Relative band density of α5 integrin, α7 integrin (A+B) and α7B integrin subunits in each day (comparing with Day -2), and for each transfection condition. The results were normalized for α-tubulin and correspond to the average of three independent transfections ± SEM (error bars). (C) Ataxin-3 is not regulating the amounts of Itga5 and Itga7 transcripts. Mock and Mjd siRNA transfected C2C12 cells at Day 0 and Day 1 of differentiation, show identical transcript levels of Itga5 and Itga7 that were measured by real-time RT-PCR. The results were normalized for the Hprt1 gene and correspond to the mean of three independent transfections ± SEM (error bars). * statistical significance p<0.05 using Student t-test. Maximum projection of confocal z-series images of double immuno-stained cells for mATX3 (1) and α5 or α7 integrin subunit (2). (A–D) C2C12 differentiated cells labeled with mATX3 (red) and α5 integrin subunit (green): at Day 1, mATX3-depleted cells are misaligned and exhibit reduced levels of mATX3 and α5 integrin subunit (B), compared to controls (A); and at Day 3, the Mjd siRNA transfected cells still present lower amounts of mATX3 and α5 integrin subunit and considerable misalignment (D) in comparison to controls (C). Note that the stronger reactivity for mATX3 in Mjd siRNA cells at Day 3 (D.1 vs B.1) is accompanied by a similar increase in α5 integrin subunit reactivity (D.2 vs B.2,). (E–F) mATX3-depleted and differentiated cells at Day 3 labeled with mATX3 (green) and α7 integrin subunit (red) show reduced levels of mATX3 and α7 integrin subunit (F) compared to controls (E). DNA was stained with DAPI (blue) as shown in the overlay (3). Scale bars represent 10 µm. To define whether mATX3 affects the expression of α5 and α7 integrin subunits at the mRNA or protein level, we extracted total RNA from mock and Mjd siRNA-transfected undifferentiated (Day 0) and differentiated cells at Day 1 (the days of maximal depletion of Mjd transcript), and performed quantitative real-time RT-PCR to determine the amounts of the respective mRNAs ( Itga5 and Itga7 ). No significant differences between mock and siRNA-depleted cells were observed for Itga5 or Itga7 mRNA levels ( Figure 3C ), suggesting that the effect on α5 and α7 integrin subunit expression occurs at the protein level. ATAXIN-3 INTERACTS WITH Α5 INTEGRIN SUBUNIT AND REPRESSES ITS DEGRADATION Several observations led us to consider the possibility that mATX3 might regulate the α5 integrin subunit degradation through the UPS: i) the expression profile of α5 integrin subunit mirrors that of mATX3 in mock- and Mjd siRNA-transfected C2C12 cells undergoing differentiation, ii) Itga5 transcript levels remain unaltered in the mATX3-depleted cells, iii) ATX3 is a DUB, and iv) α5 integrin subunit levels are known to be regulated by the UPS [15] . Therefore, we first tested mATX3 for DUB activity. We expressed several recombinant proteins, and isolated the monomeric protein by gel filtration chromatography ( Figure S2 and Materials and methods S1 ) [37] . Both the entire protein (mATX3), and the josephin domain (mATX3:jos) by itself, were able to cleave the fluorogenic substrate ubiquitin-AMC, and this activity was inhibited by mutation of the active site cysteine in mATX3:C14A and mATX:jos:C14A proteins (data not shown). As shown for other homologues, mATX3, specifically its josephin domain (mATX3:jos), is able to cleave either K48 or K63-linked polyubiquitin chains, the cysteine 14 residue being essential for this activity ( Figure S2 ). Considering the possibility that α5 integrin subunit might be a substrate of mATX3, and that its deubiquitination could act to prevent its degradation through the UPS, we tested the interaction between these two proteins. In GST-pull down assays employing recombinant GST:mATX3 and total protein extracts from E16.5 mouse embryo, endogenous α5 integrin subunit co-precipitated with GST-mATX3 ( Figure 5 ), confirming that a direct or indirect interaction between ATX3 and α5 integrin subunit occurs during mouse embryonic development. The 90KDa band pulled by GST:mATX3 and detected with the anti-α5 integrin antibody might correspond to a cleaved form of the protein. Purified recombinant GST::mATX3 protein was incubated with a whole protein extract from an E16.5 mouse embryo. Recombinant GST alone was used as control. GST pulled down samples were analyzed by immunoblotting, first with the anti-α5 integrin antibody, and then with the anti-GST antibody, following stripping. Lane 2 corresponds to 10% of the input where α5 integrin subunit can be detected as with a band of 130 KDa. Lane 4 shows that GST-mATX3 was able to pull-down α5 integrin. Note that a band of 90 KDa was also detected, which might correspond to a cleaved product of α5 integrin generated during the assay. None of the α5 integrin bands were detected in the controls (lanes 1 and 3: beads alone or beads+GST, respectively). To determine if mATX3 acts to inhibit α5 integrin subunit degradation during myogenesis, we assessed the levels of endogenous α5 integrin subunit upon protein synthesis inhibition with cycloheximide in C2C12 GFP:mATX3 overexpressing cells. The α5 integrin subunit was more abundant in these cells than in control GFP-transfected cells or in GFP::mATX3C14 (DUB catalytic mutant) overexpressing cells (all presenting the same levels of endogenous mATX3) ( Figure 6A, B ), indicating that mATX3 is able to stabilize this protein and prolong its half-life. Indeed, we verified by denature-renature immunoprecipitation assays an increase of high molecular weight (HMW) ubiquitinated α5 integrin subunit species upon UPS inhibition with MG132 in mATX3-depleted cells ( Figure 6C ), which implies that mATX3 is repressing its proteolysis at the UPS level. In contrast, cells overexpressing mATX3 show decreased levels of ubiquitinated α5 integrin subunit species, but not cells overexpressing the catalytic mutant mATX3C14A that showed a similar pattern to the empty vector-transfected cells ( Figure 6C ). (A) Effect of mATX3 overexpression in the half-life of α5 integrin subunit. C2C12 cells were transfected with the pEGFP:Mjd (GFP::mATX3), the pEGFP:MjdC14A (GFP::mATX3C14A) or the pEGFP-C1 (GFP)-empty plasmids, and after 48 hrs cells were treated with cycloheximide for 0, 30, 60 or 180 min. Whole cell extracts were collected for these time points and analyzed for the levels of endogenous α5 integrin subunit by immunoblotting. The overexpression of GFP::mATX3, but not the of GFP or the catalytic mutant GFP::mATX3C14A, was shown to stabilize the levels of α5 integrin subunit. (B) The graph represents the relative amounts of α5 integrin subunit in GFP, GFP::mATX3 and GFP::mATX3C14A overexpressing cells at various cycloheximide treatment times. The levels of endogenous mATX3 were similar in all the transfections. The results were normalized for α-tubulin and correspond to the average of three independent transfections ± SEM (error bars). (C) Denature-renature immunoprecipitation of α5 integrin subunit from Mjd siRNA, mock, GFP, GFP::mATX3, or GFP::mATX3C14A transfected C2C12 cells treated with the proteasome inhibitor MG132 at 10 µM, during 12 h. The immunoprecipitated forms of α5 integrin subunit were separated in a SDS-PAGE gel and blotted for ubiquitin and α5 integrin subunit (low and high exposure of the same blot). An increase of ubiquitinated forms of α5 integrin subunit was detected in mATX3-depleted cells. Cells overexpressing GFP::mATX3 showed a reduction in ubiquitinated α5 integrin subunit forms. No decrease of these species was observed in cells overexpressing the catalytic mutant GFP::mATX3C14A. PROTEOMIC ANALYSIS OF ATAXIN-3 DEPLETED-CELLS LEADS TO CHANGES IN THE INTEGRIN SIGNALING PATHWAY Aiming to identify proteins required for muscle differentiation, the expression of which is altered upon mATX3 repression, we performed a large-scale proteomic analysis of undifferentiated Mjd siRNA-treated C2C12 cells (Day 0). Two independent samples of total proteins extracted from C2C12 cells (mock and Mjd siRNA transfections) were labelled using the iTRAQ technology, separated by isoelectric focusing, and analyzed by LC-ESI-MS/MS. The average number of proteins detected per sample was 1634 proteins. We considered proteins with altered expression levels to be those presenting changes of 20% or more of the normal levels (1.295% statistical confidence in Protein Pilot. The quantification of the identified proteins was reported using the 114 (Day 0 mock) tag as the control with bias correction. For data analysis, a P-value<0.05 was considered for 115/114 comparison, and the expression ratio cut-off used was of 20%, i.e. were considered the ratio values smaller than 0.8 and higher than 1.2. Data analysis and molecular network pathways were created using the trial version of the Ingenuity Pathways Analysis Inc. 5.0 software, which in turn uses all the information known for a specific gene/protein including the one from their homologues in other species. The ratios were converted to fold change values through the negative inverse (-1/x) for values between 0 and 1, not affecting the values greater than 1. IMMUNOBLOTTING Total proteins from the several C2C12 differentiation days (20 µg) were resolved in appropriate SDS-PAGE polyacrylamide gels and then transferred to a nitrocellulose membrane (Hybond-C, GE Healthcare). Membranes were incubated, overnight at 4°C, with primary antibodies: anti-ATX3 antiserum (1∶5000), anti-myogenin (1∶50), anti-MyoD (1∶1000), rabbit anti-α5 integrin subunit (1∶5000), anti-α7 integrin subunit (1∶2000), anti-Arpc2 (1∶1000), anti-Arpc3 (1∶1000), anti-Cdc42 (1∶1000), anti-plectin (1∶1000), anti-talin (1∶1000) or anti-vimentin (1∶1000). All membranes were incubated with anti-α-tubulin (1∶500) for loading control. For the GST pull-down assays, bound proteins were resolved in an 8% SDS-PAGE polyacrylamide gel and transferred in the same abovementioned way. Blots were incubated with anti-GST (1∶7500) or rabbit anti-α5 integrin subunit (1∶5000) overnight at 4°C. The de-ubiquitination assays of the K48 and K63- multiubiquitin chains were immediately loaded in a 10% SDS-PAGE polyacrylamide gel, and transferred in the same above way. Membranes were incubated with a 1∶1500 dilution of a monoclonal antibody to ubiquitinylated proteins. For the immunoprecipitation assay, bound proteins were separated in a regular SDS-PAGE gel, and membranes were probed first with the anti-ubiquitin antibody (Dako) (1∶1000), and then with the rabbit anti-α5 integrin subunit antibody (1∶2000). Detection of the immunocomplexes was performed using the peroxidase-conjugated secondary antibodies anti-mouse (1∶10000), anti-rabbit (1∶10000), anti-rat (1∶10000), or anti-goat (1∶30000), and a SuperSignal West Pico Chemiluminescent Substrate (Pierce). The immunocomplexes signal was registered in ECL-films (Hyperfilm, GE Healthcare), and after that quantified using the software Quantity One 4.6.3 (Bio-Rad). STATISTICAL ANALYSIS The relative mean band density for each analyzed protein, in at least three independent immunoblottings, was compared between two groups of experiments (mock- and siRNA- transfected cells) using the t-test (calculated using the SPSS version 16.0 package). The same approach was used to analyze real-time PCR data. A significant value of p <0.05 was considered. SUPPORTING INFORMATION (0.02 MB PDF) The transcript levels of the genes encoding other josephin-domain containing proteins Josd1 , and Josd2 for mock and Mjd siRNA transfected C2C12 cells at Day 0 and Day 1 of differentiation, were measured by quantitative real-time RT-PCR, and showed to be similar. The results were normalised for the Hprt1 gene and correspond to the mean of three independent transfections +/− SEM (error bars). (0.09 MB TIF) Mouse ataxin-3 conserves the deubiquitinating activity observed for the human ataxin-3. A) Scheme of the recombinant His-tagged proteins used in this study: mATX3, the full-length protein; mATX3:C14A, the full-length protein carrying the C14A point mutation; mATX3:jos, the Josephin domain of mATX3; mATX3:jos:C14A, the Josephin domain with the C14A mutation; and mATX3:UIMs, the C-terminal of mATX3 containing the three UIMs. B) Polyubiquitin immunoblotting showing the deubiquitinating activity of each used protein. mATX3, as well as its Josephin domain for itself (mATX3:jos) were able to cleave both K48 and K63-linked polyubiquitin chains, preferentially with two or more ubiquitins. The mutation of the catalytic cysteine in these two proteins (mATX3:C14A and mATX3:jos:C14A) abolished their DUB activity. The C-terminal of mATX3 containing the UIMs (mATX3:UIMs) is not capable to hydrolyse polyubiquitin chains. (0.60 MB TIF) Proteins showing altered levels upon Mjd siRNA in undifferentiated C2C12 cells (Day 0). Cut-off (sketched line): proteins with fold changes ≥20% (1.2< ratio <0.8) considering a statistical significant p-value <0.05. Functional networks: (A) cellular movement; (B) drug metabolism; (C) protein synthesis; (D) skeletal and muscular system development and function, tissue morphology; (E) cellular development, embryonic development, cellular assembly and organization; (F) small molecule biochemistry, gene expression. (0.06 MB PDF) Primers used in this study. (0.02 MB PDF) REFERENCES [1] Bryson-Richardson RJ Currie PD 2008 The genetics of vertebrate myogenesis. Nat Rev Genet 9 632 646 [2] Sporle R 2001 Epaxial-adaxial-hypaxial regionalisation of the vertebrate somite: evidence for a somitic organiser and a mirror-image duplication. Dev Genes Evol 211 198 217 [3] Berkes CA Tapscott SJ 2005 MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 16 585 595 [4] Molkentin JD Black BL Martin JF Olson EN 1995 Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83 1125 1136 [5] Luo BH Carman CV Springer TA 2007 Structural basis of integrin regulation and signaling. Annu Rev Immunol 25 619 647 [6] Berrier AL Yamada KM 2007 Cell-matrix adhesion. J Cell Physiol 213 565 573 [7] Mayer U 2003 Integrins: redundant or important players in skeletal muscle? J Biol Chem 278 14587 14590 [8] Kim J Hoppe T 2006 The ubiquitin proteasome system and muscle development. Mayer RJ Ciechanover AJ Rechsteiner M Protein Degradation, Cell Biology of the Ubiquitin-Proteasome System Weinheim Wiley-VCH Verlag GmbH & Co. KGaA 21 47 [9] Lindon C Albagli O Domeyne P Montarras D Pinset C 2000 Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol Cell Biol 20 8923 8932 [10] Shiraishi S Zhou C Aoki T Sato N Chiba T 2007 TBP-interacting Protein 120B (TIP120B)/Cullin-associated and Neddylation-dissociated 2 (CAND2) Inhibits SCF-dependent Ubiquitination of Myogenin and Accelerates Myogenic Differentiation. J Biol Chem 282 9017 9028 [11] Boutet SC Disatnik MH Chan LS Iori K Rando TA 2007 Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. Cell 130 349 362 [12] Bounpheng MA Dimas JJ Dodds SG Christy BA 1999 Degradation of Id proteins by the ubiquitin-proteasome pathway. Faseb J 13 2257 2264 [13] Matsuzawa SI Reed JC 2001 Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7 915 926 [14] Wu G Xu G Schulman BA Jeffrey PD Harper JW 2003 Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell 11 1445 1456 [15] Kaabeche K Guenou H Bouvard D Didelot N Listrat A 2005 Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. J Cell Sci 118 1223 1232 [16] Park KC Kim JH Choi EJ Min SW Rhee S 2002 Antagonistic regulation of myogenesis by two deubiquitinating enzymes, UBP45 and UBP69. Proc Natl Acad Sci U S A 99 9733 9738 [17] Nijman SM Luna-Vargas MP Velds A Brummelkamp TR Dirac AM 2005 A genomic and functional inventory of deubiquitinating enzymes. Cell 123 773 786 [18] Chow MKM Mackay JP Whisstock JC Scanlon MJ Bottomley SP 2004 Structural and functional analysis of the josephin domain of the polyglutamine protein ataxin-3. Biochemical and Biophysical Research Communications 322 387 394 [19] Nicastro G Menon RP Masino L Knowles PP McDonald NQ 2005 The solution structure of the josephin domain of ataxin-3: structural determinants for molecular recognition. Proceedings of the National Academy of Science USA 102 10493 40498 [20] Mao Y Senic-Matuglia F Di Fiore PP Polo S Hodsdon ME 2005 Deubiquitinating function of ataxin-3: insights from the solution structure of the josephin domain. Proceedings of the National Academy of Science USA 102 12700 12705 [21] Doss-Pepe EW Stenroos ES Johnson WG Madura K 2003 Ataxin-3 interactions with Rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Molecular and Cellular Biology 23 6469 6483 [22] Chai Y Berke SS Cohen RE Paulson HL 2004 Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. The Journal of Biological Chemistry 279 3605 3611 [23] Burnett BG Li F Pittman RN 2003 The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Human Molecular Genetics 12 3195 3205 [24] Berke SJS Chai Y Marrs GL Wen H Paulson HL 2005 Defining the role of ubiquitin interacting motifs in the polyglutamine disease protein, ataxin-3. The Journal of Biological Chemistry 280 32026 32034 [25] Ferro A Carvalho AL Teixeira-Castro A Almeida C Tomé RL 2007 NEDD8: a new ataxin-3 interactor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1773 1619 1627 [26] Wang H Jia N Fei E Wang Z Liu C 2007 p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome. J Neurochem [27] Wang Q Li L Ye Y 2006 Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J Cell Biol 174 963 971 [28] Zhong X Pittman RN 2006 Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum Mol Genet 15 2409 2420 [29] Rodrigues A-J Neves-Carvalho A Ferro A Rokka A Corthals G 2009 ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in C. elegans . Biochemical Biophysical Research Communications 386 575 581 [30] Schols L Bauer P Schmidt T Schulte T Riess O 2004 Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3 291 304 [31] Coutinho P Andrade C 1978 Autosomal dominant system degeneration in Portuguese families of the Azores Islands: a new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 28 703 709 [32] Nakano KK Dawson DM Spence A 1972 Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology 22 49 55 [33] Rosenberg RN Nyhan WL Bay C Shore P 1976 Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 26 703 714 [34] Costa MC Gomes-da-Silva J Miranda CJ Sequeiros J Santos MM 2004 Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene. Genomics 84 361 373 [35] Wang G-H Sawai N Kotliarova S Kanazawa I Nukina N 2000 Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Human Molecular Genetics 9 1795 1803 [36] Tomczak KK Marinescu VD Ramoni MF Sanoudou D Montanaro F 2004 Expression profiling and identification of novel genes involved in myogenic differentiation. Faseb J 18 403 405 [37] Gales L Cortes L Almeida C Melo CV Costa MC 2005 Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. J Mol Biol 353 642 654 [38] Todi SV Winborn BJ Scaglione KM Blount JR Travis SM 2009 Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. Embo J 28 372 382 [39] Tzvetkov N Breuer P 2007 Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes. Biol Chem 388 973 978 [40] Rodrigues AJ Coppola G Santos C Costa MC Ailion M 2007 Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. Faseb Journal 21 1126 1136 [41] Lee HJ Kim MS Shin JM Park TJ Chung HM 2006 The expression patterns of deubiquitinating enzymes, USP22 and Usp22. Gene Expr Patterns 6 277 284 [42] Gousseva N Baker RT 2003 Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69. Gene Expr 11 163 179 [43] Bajanca F Luz M Duxson MJ Thorsteinsdottir S 2004 Integrins in the mouse myotome: developmental changes and differences between the epaxial and hypaxial lineage. Dev Dyn 231 402 415 [44] Gullberg D Velling T Lohikangas L Tiger CF 1998 Integrins during muscle development and in muscular dystrophies. Front Biosci 3 D1039 1050 [45] Cachaco AS Pereira CS Pardal RG Bajanca F Thorsteinsdottir S 2005 Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. Dev Dyn 232 1069 1078 [46] Noren NK Pasquale EB 2004 Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 16 655 666 [47] Geerts D Fontao L Nievers MG Schaapveld RQ Purkis PE 1999 Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J Cell Biol 147 417 434 [48] Spurny R Abdoulrahman K Janda L Runzler D Kohler G 2007 Oxidation and nitrosylation of cysteines proximal to the intermediate filament (IF)-binding site of plectin: effects on structure and vimentin binding and involvement in IF collapse. J Biol Chem 282 8175 8187 [49] Shen L Tang BS Tang JG Jiang H Wang C 2006 [Screening for proteins interacting with ataxin-3, the gene product of SCA3/MJD]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31 40 44 [50] Sun J Barbieri JT 2004 ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor. J Biol Chem 279 42936 42944 [51] Eisenmann KM McCarthy JB Simpson MA Keely PJ Guan JL 1999 Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1 507 513 [52] Zhang X Jiang G Cai Y Monkley SJ Critchley DR 2008 Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat Cell Biol 10 1062 1068 [53] Schmitt I Linden M Khazneh H Evert BO Breuer P 2007 Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem Biophys Res Commun 362 734 739 [54] Hynes RO 1996 Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol 180 402 412 [55] Fukushige T Brodigan TM Schriefer LA Waterston RH Krause M 2006 Defining the transcriptional redundancy of early bodywall muscle development in C. elegans: evidence for a unified theory of animal muscle development. Genes Dev 20 3395 3406 [56] Kafri R Levy M Pilpel Y 2006 The regulatory utilization of genetic redundancy through responsive backup circuits. Proc Natl Acad Sci U S A 103 11653 11658 [57] Rudnicki MA Jaenisch R 1995 The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17 203 209 [58] Kawaguchi Y Okamoto T Taniwaki M Aizawa M Inoue M 1994 CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics 8 221 228 [59] Webb DJ Zhang H Majumdar D Horwitz AF 2007 alpha5 integrin signaling regulates the formation of spines and synapses in hippocampal neurons. J Biol Chem 282 6929 6935 [60] Khan LA Bauer PO Miyazaki H Lindenberg KS Landwehrmeyer BG 2006 Expanded polyglutamines impair synaptic transmission and ubiquitin-proteasome system in Caenorhabditis elegans. J Neurochem 98 576 587